P

Inventor

CHOI IN YOUNG

KR51 patents
⚠️ This page may combine multiple inventors who share the name “CHOI IN YOUNG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HANMI PHARM IND CO LTD

19 patents
US7736653B2Jun 15, 2010

Pharmaceutical composition comprising an immunoglobulin Fc region as a carrier

HANMI PHARM IND CO LTD80 citations97
US9901621B2Feb 27, 2018

Composition for treating hyperlipidemia comprising oxyntomodulin derivative

HANMI PHARM IND CO LTD5 citations84
US11667688B2Jun 6, 2023

Glucagon derivative and a composition comprising a long acting conjugate of the same

HANMI PHARM IND CO LTD1 citations73
US11261227B2Mar 1, 2022

Glucagon derivative and a composition comprising a long acting conjugate of the same

HANMI PHARM IND CO LTD1 citations73
US10696725B2Jun 30, 2020

Glucagon derivative and a composition comprising a long acting conjugate of the same

HANMI PHARM IND CO LTD3 citations73
US10493132B2Dec 3, 2019

Composition for treating hyperlipidemia comprising oxyntomodulin derivative

HANMI PHARM IND CO LTD2 citations73
US10435459B2Oct 8, 2019

Use of a long acting GLP-1/glucagon receptor dual agonist for the treatment of non-alcoholic fatty liver disease

HANMI PHARM IND CO LTD2 citations72
US10159715B2Dec 25, 2018

Method for treating diabetes comprising long-acting insulin analogue conjugate and long-acting insulinotropic peptide conjugate

HANMI PHARM IND CO LTD3 citations72
US9663565B2May 30, 2017

Insulinotropic peptide derivative with modified N-terminal charge

HANMI PHARM IND CO LTD2 citations72
US11530249B2Dec 20, 2022

Long-acting conjugates of GLP-2 derivatives

HANMI PHARM IND CO LTD0 citations62
US11147857B2Oct 19, 2021

IgG4 Fc fragment comprising modified hinge region

HANMI PHARM IND CO LTD0 citations62
US11142559B2Oct 12, 2021

Glucagon derivative, conjugate thereof, composition comprising same, and therapeutic use thereof

HANMI PHARM IND CO LTD1 citations62
US10973881B2Apr 13, 2021

IgG4 Fc fragment comprising modified hinge region

HANMI PHARM IND CO LTD1 citations62
US10233230B2Mar 19, 2019

Use of a long acting GLP-1/glucagon receptor dual agonist for the treatment of non-alcoholic fatty liver disease

HANMI PHARM IND CO LTD1 citations62
US10188703B2Jan 29, 2019

Method for treating diabetes mellitus by a composition comprising insulin and a GLP-1/glucagon dual agonist

HANMI PHARM IND CO LTD1 citations62
US11752216B2Sep 12, 2023

Insulin analog complex with reduced affinity for insulin receptor and use thereof

HANMI PHARM IND CO LTD0 citations52
US10647753B2May 12, 2020

Insulin analogs and use thereof

HANMI PHARM IND CO LTD0 citations52
US10017557B2Jul 10, 2018

Insulin analogs and use thereof

HANMI PHARM IND CO LTD0 citations52
US11396534B2Jul 26, 2022

Insulin analogs with reduced affinity to insulin receptor and use thereof

HANMI PHARM IND CO LTD0 citations48

SAMSUNG ELECTRONICS CO LTD

9 patents

CHOI IN YOUNG

3 patents

HYUNDAI MOTOR CO LTD

3 patents

JUNG SUNG YOUB

2 patents

HANMI SCIENCE CO LTD

2 patents

DONGBU HANNONG CHEMICAL CO LTD

2 patents

UNIV SOUTHERN CALIFORNIA

2 patents

KIM YOUNG MIN

1 patent

SONG DAE HAE

1 patent

WOO YOUNG EUN

1 patent

KIM CHANG HWAN

1 patent

DONGBU FARM HANNONG CO LTD

1 patent

KO YOUNG KWAN

1 patent

HANMI PHARMACEUTICAL CO LTD

1 patent

J&C SCIENCES

1 patent

Showing the top 50 of 51 patents by PatentIndex Score.